(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.data-privacy-src=g;m.parentNode.insertBefore(a,m) })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-1666707-3', 'auto'); ga('send', 'pageview');

zdravko.mauko

About Zdravko Mauko

This author has not yet filled in any details.
So far Zdravko Mauko has created 59 blog entries.

New Generation of Software for More Efficient Clinical Trials and Multicentre Projects

Beside the software, IT provider will usually provide tailor made adjustment of software and IT support during project. Application will be a user-friendly, scalable and secure. It will run form

By |2020-04-01T12:49:47+01:00August 23rd, 2006|Clinical trials|0 Comments

How to Calculate Standard Patent Expiry Dates and Data Exclusivity in Key Territories

Use this handy guide to navigate the calculation of patent expiry dates in US, Canada, Germany, Spain, France, United Kingdom and Australia, and also data exclusivity in the US, Canada,

By |2020-04-01T12:49:48+01:00March 1st, 2006|Research & Development|0 Comments

New Legal Framework for Harmonisation of the Data Exclusivity

The new periods of data exclusivity will only take effect for reference products applying for marketing authorisation after the new law is fully in effect (around November 2005). Therefore, the

By |2020-04-01T12:49:48+01:00November 29th, 2005|Regulatory Affairs|0 Comments
Go to Top